Deadline Alert: Picard Medical, Inc. (PMI) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming April 3, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Picard Medical, Inc. (“Picard” or the “Company”) (NYSE American: PMI) securities between September 2, 2025 and October 31, 2025, inclusive (the “Class Period”).
Deadline Approaching: Picard Medical, Inc. (PMI) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Law Offices of Howard G. Smith reminds investors of the upcoming April 3, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Picard Medical, Inc. (“Picard” or the “Company”) (NYSE American: PMI) securities between September 2, 2025 and October 31, 2025, inclusive (the “Class Period”).
CORRECTING and REPLACING Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Picard Medical Inc. (NASDAQ: PMI)
The lead plaintiff deadline throughout the release dated February 3, 2026, should read April 13, 2026 (instead of April 3, 2026).
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Picard Medical, Inc. (PMI) Shareholders to Inquire About Securities Fraud Class Action
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Picard Medical, Inc. (“Picard” or the “Company”) (NYSE American: PMI) securities between September 2, 2025 and October 31, 2025, inclusive (the “Class Period”). Picard investors have until April 3, 2026 to file a lead plaintiff motion.
Law Offices of Frank R. Cruz Encourages Picard Medical, Inc. (PMI) Shareholders To Inquire About Securities Fraud Class Action
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Picard Medical, Inc. (“Picard” or the “Company”) (
NYSE: PMI) securities between September 2, 2025 and October 31, 2025, inclusive (the “Class Period”). Picard investors have until April 3, 2026 to file a lead plaintiff motion.
Law Offices of Howard G. Smith Encourages Picard Medical, Inc. (PMI) Shareholders To Inquire About Securities Fraud Class Action
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Picard Medical, Inc. (“Picard” or the “Company”) (
NYSE: PMI) securities between September 2, 2025 and October 31, 2025, inclusive (the “Class Period”). Picard investors have until April 3, 2026 to file a lead plaintiff motion.
Securities Fraud Investigation Into Picard Medical, Inc. (PMI) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Picard Medical, Inc. (“Picard” or the “Company”) (
NYSE: PMI) investors concerning the Company’s possible violations of the federal securities laws.
Picard Medical, Inc. (PMI) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Picard Medical, Inc. (“Picard” or the “Company”) (
NYSE: PMI) investors concerning the Company’s possible violations of federal securities laws.
Picard Medical, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – PMI
The DJS Law Group reminds investors of a class action lawsuit against Picard Medical, Inc. (“Picard” or “the Company”) (NYSE American: PMI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Securities Fraud Investigation Into Picard Medical, Inc. (PMI) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Picard Medical, Inc. (“Picard” or the “Company”) (
NYSE: PMI) on behalf of investors concerning the Company’s possible violations of federal securities laws.
PMI Investors Have Opportunity to Lead Picard Medical, Inc. Securities Fraud Lawsuit With the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Picard Medical, Inc. (“Picard” or “the Company”) (NYSE American: PMI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Picard MedicalFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Picard Medical To Contact Him Directly To Discuss Their Options
Rosen Law Firm Urges Picard Medical, Inc. (NYSE American: PMI) Stockholders With Large Losses to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Picard Medical, Inc. (NYSE American: PMI) between September 2, 2025 and October 31, 2025, inclusive (the “Class Period”). Picard claims to design, manufacture, and sell medical device products.
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Picard Medical, Inc. Securities Class Action Lawsuit
Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Picard Medical, Inc. (
NYSE: PMI) securities between September 2, 2025 and October 31, 2025. Picard Medical claims to engage in designing, manufacturing, production, supply, marketing, and sale of medical device products.
